| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
51,119 |
44,735 |
$8.21M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
52,160 |
44,684 |
$6.79M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
31,633 |
27,650 |
$2.57M |
| 36415 |
Collection of venous blood by venipuncture |
46,020 |
38,820 |
$509K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
426 |
417 |
$276K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,047 |
918 |
$241K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,122 |
1,665 |
$241K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,864 |
2,476 |
$149K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,320 |
2,127 |
$138K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,447 |
3,704 |
$132K |
| 80053 |
Comprehensive metabolic panel |
12,812 |
11,368 |
$120K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,713 |
3,485 |
$103K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,223 |
1,044 |
$99K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,464 |
19,521 |
$92K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,234 |
1,031 |
$86K |
| G0378 |
Hospital observation service, per hour |
1,752 |
1,395 |
$85K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,559 |
2,160 |
$84K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
691 |
580 |
$81K |
| 93296 |
|
3,755 |
3,576 |
$76K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
523 |
437 |
$74K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,363 |
7,724 |
$68K |
| 0002A |
|
1,770 |
1,733 |
$54K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
7,976 |
3,527 |
$53K |
| 0001A |
|
1,932 |
1,804 |
$48K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
384 |
374 |
$46K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,730 |
5,716 |
$43K |
| 84484 |
|
4,617 |
3,090 |
$32K |
| 85027 |
|
6,765 |
5,553 |
$28K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,288 |
1,969 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
2,266 |
1,893 |
$24K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
311 |
194 |
$23K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
135 |
100 |
$22K |
| 82962 |
|
10,004 |
2,247 |
$20K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
51 |
49 |
$19K |
| 83605 |
|
2,842 |
2,208 |
$18K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
268 |
247 |
$18K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,390 |
2,790 |
$17K |
| 83735 |
|
3,817 |
2,954 |
$16K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
107 |
98 |
$15K |
| 86140 |
|
3,228 |
2,793 |
$13K |
| 93017 |
|
357 |
292 |
$12K |
| A9270 |
Non-covered item or service |
21,215 |
2,488 |
$11K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
944 |
814 |
$11K |
| 82077 |
|
2,113 |
1,805 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,155 |
1,654 |
$9K |
| 84703 |
|
1,475 |
1,259 |
$9K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
108 |
100 |
$9K |
| 81001 |
|
2,266 |
1,963 |
$8K |
| 85610 |
|
3,394 |
2,726 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
250 |
211 |
$7K |
| 83690 |
|
1,438 |
1,198 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
7,547 |
5,808 |
$7K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
110 |
89 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,007 |
591 |
$6K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
33 |
26 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
145 |
96 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
112 |
86 |
$5K |
| 0012A |
|
142 |
139 |
$4K |
| G0400 |
Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels |
56 |
52 |
$4K |
| 87632 |
|
61 |
57 |
$4K |
| 0011A |
|
142 |
136 |
$4K |
| 81003 |
|
902 |
802 |
$4K |
| 82248 |
|
1,290 |
1,145 |
$3K |
| 99152 |
|
718 |
589 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
181 |
57 |
$3K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
14 |
$2K |
| C1769 |
Guide wire |
647 |
540 |
$2K |
| 83880 |
|
123 |
107 |
$2K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
64 |
57 |
$2K |
| 99153 |
Mod sedat endo service >5yrs |
290 |
245 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,163 |
4,083 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,059 |
466 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
6,500 |
4,142 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,534 |
3,480 |
$2K |
| 84145 |
|
127 |
107 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
352 |
310 |
$2K |
| 84132 |
|
891 |
740 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
610 |
528 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,478 |
1,285 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,334 |
3,299 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
62 |
57 |
$1K |
| 96376 |
|
556 |
294 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
138 |
125 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
20 |
15 |
$1K |
| 95806 |
|
26 |
26 |
$1K |
| 87040 |
|
237 |
107 |
$1K |
| 85379 |
|
100 |
93 |
$1K |
| 86900 |
|
357 |
306 |
$1K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
300 |
229 |
$1K |
| 86850 |
|
285 |
253 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,198 |
2,627 |
$819.24 |
| 86901 |
|
357 |
306 |
$770.10 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,286 |
1,873 |
$689.05 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
172 |
81 |
$678.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,489 |
1,649 |
$654.71 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
40 |
14 |
$598.55 |
| 0031A |
|
26 |
26 |
$524.27 |
| 80143 |
|
48 |
40 |
$491.11 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,126 |
1,544 |
$467.76 |
| 87077 |
|
125 |
86 |
$448.46 |
| 93226 |
|
53 |
49 |
$418.64 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,228 |
2,490 |
$353.53 |
| J3490 |
Unclassified drugs |
487 |
347 |
$345.66 |
| 85018 |
|
185 |
114 |
$338.30 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
669 |
491 |
$319.98 |
| 97161 |
|
13 |
12 |
$244.64 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
75 |
60 |
$229.06 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
106 |
87 |
$219.33 |
| J1815 |
Injection, insulin, per 5 units |
117 |
55 |
$214.30 |
| 80179 |
|
20 |
13 |
$208.98 |
| J2785 |
Injection, regadenoson, 0.1 mg |
47 |
36 |
$207.37 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15 |
13 |
$206.93 |
| 87186 |
|
72 |
52 |
$202.05 |
| 85730 |
|
29 |
27 |
$135.18 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
367 |
324 |
$122.74 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
104 |
91 |
$118.28 |
| 82565 |
|
49 |
44 |
$116.56 |
| 88342 |
|
55 |
39 |
$112.64 |
| 76937 |
|
35 |
28 |
$93.42 |
| Q3014 |
Telehealth originating site facility fee |
66 |
63 |
$79.95 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
46 |
38 |
$75.00 |
| 84702 |
|
12 |
12 |
$66.64 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
17 |
14 |
$56.25 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
121 |
91 |
$52.80 |
| 87070 |
|
14 |
12 |
$43.79 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
42 |
36 |
$35.20 |
| 87205 |
|
16 |
13 |
$26.10 |
| J7999 |
Compounded drug, not otherwise classified |
58 |
45 |
$17.60 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
57 |
52 |
$17.15 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
16 |
12 |
$6.76 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,305 |
1,015 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
16 |
13 |
$0.00 |
| 91300 |
|
410 |
343 |
$0.00 |
| 88173 |
|
24 |
13 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
16 |
15 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
17 |
12 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
14 |
13 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
15 |
12 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
73 |
65 |
$0.00 |
| 88341 |
|
52 |
12 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
20 |
12 |
$0.00 |